Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2014, Article ID 636238, 8 pages
http://dx.doi.org/10.1155/2014/636238
Research Article

Interplay of T Helper 17 Cells with CD4+CD25high FOXP3+ Tregs in Regulation of Allergic Asthma in Pediatric Patients

1Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India
2Department of Natural Science, West Bengal University of Technology, Kolkata 700064, India
3Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India

Received 3 March 2014; Revised 6 May 2014; Accepted 11 May 2014; Published 4 June 2014

Academic Editor: Emmanuel Katsanis

Copyright © 2014 Amit Agarwal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. von Mutius, “Influences in allergy: epidemiology and the environment,” Journal of Allergy and Clinical Immunology, vol. 113, no. 3, pp. 373–380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Y. Kim, R. H. Dekruyff, and D. T. Umetsu, “The many paths to asthma: phenotype shaped by innate and adaptive immunity,” Nature Immunology, vol. 11, no. 7, pp. 577–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Larché, D. S. Robinson, and A. B. Kay, “The role of T lymphocytes in the pathogenesis of asthma,” Journal of Allergy and Clinical Immunology, vol. 111, no. 3, pp. 450–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Baraldo, K. L. Oliani, G. Turato, R. Zuin, and M. Saetta, “The role of lymphocytes in the pathogenesis of asthma and COPD,” Current Medicinal Chemistry, vol. 14, no. 21, pp. 2250–2256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Afshar, B. D. Medoff, and A. D. Luster, “Allergic asthma: a tale of many T cells,” Clinical and Experimental Allergy, vol. 38, no. 12, pp. 1847–1857, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Akdis and M. Akdis, “Mechanisms and treatment of allergic disease in the big picture of regulatory T cells,” Journal of Allergy and Clinical Immunology, vol. 123, no. 4, pp. 735–746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Bluestone and A. K. Abbas, “Natural versus adaptive regulatory T cells,” Nature Reviews Immunology, vol. 3, no. 3, pp. 253–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Fontenot and A. Y. Rudensky, “A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3,” Nature Immunology, vol. 6, no. 4, pp. 331–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4+CD25+ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Sakaguchi, M. Ono, R. Setoguchi et al., “Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease,” Immunological Reviews, vol. 212, pp. 8–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Y. Wan and R. A. Flavell, “Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression,” Nature, vol. 445, no. 7129, pp. 766–770, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Baecher-Allan, J. A. Brown, G. J. Freeman, and D. A. Hafler, “CD4+CD25high regulatory cells in human peripheral blood,” Journal of Immunology, vol. 167, no. 3, pp. 1245–1253, 2001. View at Google Scholar · View at Scopus
  15. S. Fowler and F. Powrie, “Control of immune pathology by IL-10-secreting regulatory T cells,” Springer Seminars in Immunopathology, vol. 21, no. 3, pp. 287–294, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Powrie, J. Carlino, M. W. Leach, S. Mauze, and R. L. Coffman, “A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells,” The Journal of Experimental Medicine, vol. 183, no. 6, pp. 2669–2674, 1996. View at Publisher · View at Google Scholar
  17. D. Hartl, B. Koller, A. T. Mehlhorn et al., “Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma,” Journal of Allergy and Clinical Immunology, vol. 119, no. 5, pp. 1258–1266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Peck and E. D. Mellins, “Plasticity of T-cell phenotype and function: the T helper type 17 example,” Immunology, vol. 129, no. 2, pp. 147–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Awasthi and V. K. Kuchroo, “Th17 cells: from precursors to players in inflammation and infection,” International Immunology, vol. 21, no. 5, pp. 489–498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Wakashin, K. Hirose, Y. Maezawa et al., “IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 10, pp. 1023–1032, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. H. Wilson, G. S. Whitehead, H. Nakano, M. E. Free, J. K. Kolls, and D. N. Cook, “Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 8, pp. 720–730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Curtis and S. S. Way, “Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens,” Immunology, vol. 126, no. 2, pp. 177–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Fujino, A. Andoh, S. Bamba et al., “Increased expression of interleukin 17 in inflammatory bowel disease,” Gut, vol. 52, no. 1, pp. 65–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. C. E. Jones and K. Chan, “Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 6, pp. 748–753, 2002. View at Google Scholar · View at Scopus
  26. S. Ivanov and A. Lindén, “Interleukin-17 as a drug target in human disease,” Trends in Pharmacological Sciences, vol. 30, no. 2, pp. 95–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Kim, J. P. Rasmussen, and A. Y. Rudensky, “Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice,” Nature Immunology, vol. 8, no. 2, pp. 191–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Annunziato, L. Cosmi, V. Santarlasci et al., “Phenotypic and functional features of human Th17 cells,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849–1861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. O'Connor, K. H. Malpass, and S. M. Anderton, “The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells,” Journal of Immunology, vol. 179, no. 2, pp. 958–966, 2007. View at Google Scholar · View at Scopus
  30. A. Mubeccel, “Immune tolerance in allergy,” Current Opinion in Immunology, vol. 21, no. 6, pp. 700–707, 2009. View at Publisher · View at Google Scholar
  31. M. R. Walker, D. J. Kasprowicz, V. H. Gersuk et al., “Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells,” Journal of Clinical Investigation, vol. 112, no. 9, pp. 1437–1443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Murphy and P. M. O'Byrne, “Recent advances in the pathophysiology of asthma,” Chest, vol. 137, no. 6, pp. 1417–1426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Veldhoen and B. Stockinger, “TGFβ1, a “Jack of all trades”: the link with pro-inflammatory IL-17-producing T cells,” Trends in Immunology, vol. 27, no. 8, pp. 358–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Mai, H. Wang, and X.-F. Yang, “Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity,” Frontiers in Bioscience, vol. 15, no. 3, pp. 986–1006, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. T. A. Chatila, “Role of regulatory T cells in human diseases,” Journal of Allergy and Clinical Immunology, vol. 116, no. 5, pp. 949–960, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Akdis, K. Blaser, and C. A. Akdis, “T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases,” Journal of Allergy and Clinical Immunology, vol. 116, no. 5, pp. 961–969, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Gavin, J. P. Rasmussen, J. D. Fontenot et al., “Foxp3-dependent programme of regulatory T-cell differentiation,” Nature, vol. 445, no. 7129, pp. 771–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Jartti, K. A. Burmeister, C. M. Seroogy et al., “Association between CD4+CD25high T cells and atopy in children,” Journal of Allergy and Clinical Immunology, vol. 120, no. 1, pp. 177–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. W. G. Shreffler, N. Wanich, M. Moloney, A. Nowak-Wegrzyn, and H. A. Sampson, “Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein,” Journal of Allergy and Clinical Immunology, vol. 123, no. 1, pp. 43.e7–52.e7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Smith, M. R. Tourigny, P. Noakes, C. A. Thornton, M. K. Tulic, and S. L. Prescott, “Children with egg allergy have evidence of reduced neonatal CD4+CD25+CD127lo/- regulatory T cell function,” Journal of Allergy and Clinical Immunology, vol. 121, no. 6, pp. 1460.e7–1466.e7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. M. Tiemessen, E. van Hoffen, A. C. Knulst, J.-A. van der Zee, E. F. Knol, and L. S. Taams, “CD4+CD25+ regulatory T cells are not functionally impaired in adult patients with IgE-mediated cow's milk allergy,” Journal of Allergy and Clinical Immunology, vol. 110, no. 6, pp. 934–936, 2002. View at Google Scholar · View at Scopus
  42. L.-S. Ou, E. Goleva, C. Hall, and D. Y. M. Leung, “T regulatory cells in atopic dermatitis and subversion of their activity by superantigens,” Journal of Allergy and Clinical Immunology, vol. 113, no. 4, pp. 756–763, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. Taylor, J. Hale, B. J. Hales, J. A. Dunstan, W. R. Thomas, and S. L. Prescott, “FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth,” Pediatric Allergy and Immunology, vol. 18, no. 1, pp. 10–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Molet, Q. Hamid, F. Davoine et al., “IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines,” Journal of Allergy and Clinical Immunology, vol. 108, no. 3, pp. 430–438, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Barczyk, W. Pierzcha, and E. Sozañska, “Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine,” Respiratory Medicine, vol. 97, no. 6, pp. 726–733, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. D. M. A. Bullens, E. Truyen, L. Coteur et al., “IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?” Respiratory Research, vol. 7, article 135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. C. K. Wong, C. Y. Ho, F. W. S. Ko et al., “Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ, IL-4, IL-10 and IL-13) in patients with allergic asthma,” Clinical and Experimental Immunology, vol. 125, no. 2, pp. 177–183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. L. A. Tesmer, S. K. Lundy, S. Sarkar, and D. A. Fox, “Th17 cells in human disease,” Immunological Reviews, vol. 223, no. 1, pp. 87–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Jutel, M. Akdis, F. Budak et al., “IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy,” European Journal of Immunology, vol. 33, no. 5, pp. 1205–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. C. M. Baecher-Allan and D. A. Hafler, “Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells,” Clinical Immunology, vol. 117, no. 2, pp. 192–193, 2005. View at Google Scholar · View at Scopus